Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease.

Autor: Colaneri M; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.; Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, Italy., Scaglione G; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy., Fassio F; Department of Public Health, Experimental and Forensic Medicine, Unit of Biostatistics and Clinical Epidemiology, University of Pavia, Pavia, Italy., Galli L; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy., Lai A; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy., Bergna A; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy., Gabrieli A; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy., Tarkowski M; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy., Ventura CD; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy., Colombo V; Department of Infectious Diseases, Unit I, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy., Cordier L; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy., Bernasconi D; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy., Corbellino M; Institute of Infectious Diseases & Tropical Medicine, III Division, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy., Dedivitiis G; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy., Borghetti S; Pharmacy Unit, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy., Visigalli D; Pharmacy Unit, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy., Sollima S; Institute of Infectious Diseases & Tropical Medicine, III Division, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy., Casalini G; Institute of Infectious Diseases & Tropical Medicine, III Division, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy., Rizzardini G; Department of Infectious Diseases, Unit I, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy., Gori A; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.; Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, Italy., Antinori S; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.; Institute of Infectious Diseases & Tropical Medicine, III Division, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy., Riva A; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.; Institute of Infectious Diseases & Tropical Medicine, III Division, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy., Schiavini M; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy. schiavini.monica@asst-fbf-sacco.it.

Publikováno v: Virology journal [Virol J] 2024 Mar 20; Vol. 21 (1), pp. 68. Date of Electronic Publication: 2024 Mar 20.

Prise en charge de l'infection par le virus de l'hépatite B chez les patients atteints de polyarthrite rhumatoïde: conférence de consensus italienne [Italian consensus guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis]

Autor: Sebastiani, M., Atzeni, F., Milazzo, L., Quartuccio, L., Scire, C., Gaeta, G. B., Lapadula, G., Armignacco, O., Tavio, M., Olivieri, I., Meroni, P., Bazzichi, L., Grassi, W., Mathieu, A., Mastroianni, C., Sagnelli, E., Santantonio, T., Uberti Foppa, C., Puoti, M., Sarmati, L., Airo, P., Epis, O. M., Scrivo, R., Gargiulo, M., Riva, A., Manfredi, A., Ciancio, G., Zehender, G., Taliani, G., Meroni, L., Sollima, S., Sarzi-Puttini, P., Galli, M.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3674::a76bd457560e500bfe10c7eac7f1ab26
https://hdl.handle.net/11380/1221855

Sofosbuvir/Ribavirin in GT2 HCV-Related symptomatic mixed cryoglobulinemia: an interim analysis on safety, efficacy and impact on quality of life

Autor: Cerretelli, G, Monti, M, Gragnani, L, Arena, U, Fognani, E, Petraccia, L, Stasi, C, Basile, U, Sollima, S, Brancaccio, G, Galli, M, G B, Gaeta, Laffi, G, A L, Zignego

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0dec8f962aff83fa1f2b2ea3054f61d7
http://hdl.handle.net/11573/1586563

The progress and future of the treatment of Candida albicans infections based on nanotechnology.

Autor: Gao, Yang¹ (AUTHOR), Cao, Qinyan¹ (AUTHOR), Xiao, Yuyang¹ (AUTHOR), Wu, Yue¹ (AUTHOR), Ding, Liang² (AUTHOR), Huang, He¹ (AUTHOR), Li, Yanan¹ (AUTHOR) liyanan@njnu.edu.cn, Yang, Jingpeng¹ (AUTHOR) yang_jp008@163.com, Meng, Lingtong¹ (AUTHOR) mlt_nju@163.com

Publikováno v: Journal of Nanobiotechnology. 9/16/2024, Vol. 22 Issue 1, p1-23. 23p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.